In other tumors such as pancreatic carcinoma, non-small cell lung cancer and melanoma GALNT14 expression was observed to correlate with Apo2L/TRAIL sensitivity to proapoptotic signaling through O-glycosylation of Apo2L/TRAIL death receptors [38]. This evidence concerns the gene TNFSF10 and melanoma.